Enterococcus casseliflavus septicaemia associated with hepatobiliary infection in a 75-year-old man
- 1Department of Hospital Medicine, Augusta Health, Fishersville, Virginia, USA
- 2Hospital Medicine, United Hospital, Allina Health, St Paul, Minnesota, USA
- Correspondence to Dr Rajanshu Verma,
- Accepted 27 April 2017
- Published 12 May 2017
Enterococcus casseliflavus is a rare non-faecium, non-faecalis, vancomycin-resistant enterococcus (VRE) that is responsible for up to 2% of all enterococcal infections. Septicaemia with this bacterium is usually seen in older patients with multiple comorbidities who have had several previous hospitalisations. Septicaemia with E. casseliflavus portends a poorer prognosis, and treatment usually involves administration of antienterococcal beta-lactams or anti-VRE medications such as linezolid or daptomycin. We present such a case of a 75-year-old man who developed E. casseliflavus septicaemia of presumably hepatobiliary origin and responded well to treatment with intravenous beta-lactams.
Contributors Both RV and ALB took care of the patient. Both RV and ALB contributed to the manuscript, edited and approved the final draft.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.